Gemcitabine-based combination chemotherapy as salvage treatment for refractory or relapsing aggressive non-Hodgkin's lymphomaYANG, Shih-Hung; LIN, Zhong-Zhe; KUO, Sung-Hsin et al.American journal of hematology. 2009, Vol 84, Num 7, pp 457-459, issn 0361-8609, 3 p.Article

Specific EGFR Mutations Predict Treatment Outcome of Stage IIIB/IV Patients With Chemotherapy-Naive Non-Small-Cell Lung Cancer Receiving First-Line Gefitinib MonotherapyYANG, Chih-Hsin; YU, Chong-Jen; HUANG, Chin-Lun et al.Journal of clinical oncology. 2008, Vol 26, Num 16, pp 2745-2753, issn 0732-183X, 9 p.Article

Nuclear Overexpression of Mitotic Regulatory Proteins in Biliary Tract Cancer : Correlation with Clinicopathologic Features and Patient SurvivalSHEN, Ying-Chun; HU, Fu-Chang; JENG, Yung-Ming et al.Cancer epidemiology, biomarkers & prevention. 2009, Vol 18, Num 2, pp 417-423, issn 1055-9965, 7 p.Article

The Aurora kinase inhibitor VE-465 has anticancer effects in pre-clinical studies of human hepatocellular carcinomaLIN, Zhong-Zhe; HSU, Hey-Chi; JENG, Yung-Ming et al.Journal of hepatology. 2009, Vol 50, Num 3, pp 518-527, issn 0168-8278, 10 p.Article

Efficacy, Safety, and Potential Biomarkers of Thalidomide plus Metronomic Chemotherapy for Advanced Hepatocellular CarcinomaSHAO, Yu-Yun; LIN, Zhong-Zhe; HSU, Chiun et al.Oncology. 2012, Vol 82, Num 1, pp 59-66, issn 0030-2414, 8 p.Article

Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinomaHSU, Chih-Hung; SHEN, Ying-Chun; LIN, Zhong-Zhe et al.Journal of hepatology. 2010, Vol 53, Num 1, pp 126-131, issn 0168-8278, 6 p.Article

Efficacy of a novel histone deacetylase inhibitor in murine models of hepatocellular carcinomaLU, Yen-Shen; KASHIDA, Yoko; CLIEN, Ching-Shih et al.Hepatology (Baltimore, Md.). 2007, Vol 46, Num 4, pp 1119-1130, issn 0270-9139, 12 p.Article

Comparison of gefitinib and erlotinib efficacies as third-line therapy for advanced non-small-cell lung cancerSHAO, Yu-Yun; SHAU, Wen-Yi; LIN, Zhong-Zhe et al.European journal of cancer (1990). 2013, Vol 49, Num 1, pp 106-114, issn 0959-8049, 9 p.Article

Impact of Baseline Hepatitis B Viral DNA Levels on Survival of Patients with Advanced Hepatocellular CarcinomaSHAO, Yu-Yun; CHEN, Pei-Jer; LIN, Zhong-Zhe et al.Anticancer research. 2011, Vol 31, Num 11, pp 4007-4011, issn 0250-7005, 5 p.Article

EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatmentHUANG, Chin-Lun; YANG, Chih-Hsin; YEH, Kun-Huei et al.Lung cancer. 2009, Vol 64, Num 3, pp 346-351, issn 0169-5002, 6 p.Article

Radiosensitization by combining an aurora kinase inhibitor with radiotherapy in hepatocellular carcinoma through cell cycle interruptionLIN, Zhong-Zhe; CHOU, Chia-Hung; CHENG, Ann-Lii et al.International journal of cancer (Print). 2014, Vol 135, Num 2, pp 492-501, issn 0020-7136, 10 p.Article

Hospital Volume of Percutaneous Radiofrequency Ablation is Closely Associated With Treatment Outcomes for Patients With Hepatocellular CarcinomaLU, Li-Chun; SHAO, Yu-Yun; KUO, Raymond N. C et al.Cancer. 2013, Vol 119, Num 6, pp 1210-1216, issn 0008-543X, 7 p.Article

Survival of Patients with Small Cell Lung Carcinoma in TaiwanKUO, Yu-Hsuan; LIN, Zhong-Zhe; YANG, Yen-Yun et al.Oncology. 2012, Vol 82, Num 1, pp 19-24, issn 0030-2414, 6 p.Article

Early Alpha-Fetoprotein Response Predicts Treatment Efficacy of Antiangiogenic Systemic Therapy in Patients With Advanced Hepatocellular CarcinomaSHAO, Yu-Yun; LIN, Zhong-Zhe; HSU, Chiun et al.Cancer. 2010, Vol 116, Num 19, pp 4590-4596, issn 0008-543X, 7 p.Article

High Circulating Endothelial Progenitor Levels Associated with Poor Survival of Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib Combined with Metronomic ChemotherapySHAO, Yu-Yun; LIN, Zhong-Zhe; CHEN, Te-Jung et al.Oncology. 2011, Vol 81, Num 2, pp 98-103, issn 0030-2414, 6 p.Article

Gastric Perforation Presenting as Empyema in a Patient with Pancreatic Cancer on Bevacizumab TreatmentSHAO, Yu-Yun; LIN, Zhong-Zhe; LIANG, Po-Chin et al.Anticancer research. 2009, Vol 29, Num 5, pp 1665-1667, issn 0250-7005, 3 p.Article

High efficacy of erlotinib in Taiwanese NSCLC patients in an expanded access program study previously treated with chemotherapyPERNG, Reury-Perng; YANG, Chih-Hsin; HSIA, Te-Chun et al.Lung cancer. 2008, Vol 62, Num 1, pp 78-84, issn 0169-5002, 7 p.Article

Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatmentLIN, Zhong-Zhe; HSU, Chiun; CHANG, Yeun-Chung et al.Lung cancer. 2008, Vol 60, Num 2, pp 215-221, issn 0169-5002, 7 p.Article